Benjamin Adler

Benjamin Adler has a diverse work experience that spans various roles in the biotechnology and finance sectors. Benjamin is currently working at SpringWorks Therapeutics as the Vice President of Strategy and Business Development, a position they have held since January 2023. Prior to this, they served as the Senior Director and Director of Strategy and Business Development at the same company from 2019 to 2022 and 2019 to 2021 respectively.

Before joining SpringWorks Therapeutics, Benjamin worked as a Vice President at Leerink Partners LLC from April 2018 to March 2019. Benjamin also gained valuable experience in equity research at Morgan Stanley and Piper Jaffray, where they served as an Equity Research Associate in the biotechnology sector from 2016 to 2018 and 2014 to 2016 respectively.

Benjamin's educational background includes a Ph.D. from Stony Brook University, where they were a Ph.D. student from September 2007 to August 2013. Benjamin later served as a Postdoctoral Fellow at the university from September 2013 to September 2014. Additionally, they worked as a Research Support Specialist at Stony Brook University from January 2005 to August 2005.

Benjamin Adler earned a Bachelor of Engineering in Biomedical Engineering from Stony Brook University in 2004. Benjamin later pursued a Master of Science degree in Biomedical Engineering from the same university, completing it in 2009. Continuing their education, Benjamin obtained a Ph.D. in Biomedical Engineering from Stony Brook University in 2013. There is no information provided regarding their educational experience prior to attending Stony Brook University or any additional certifications they may have obtained.